Unknown

Dataset Information

0

Editorial: COVID-19 and Multisystem Inflammatory Syndrome in Children (MIS-C).


ABSTRACT: In early 2020, at the beginning of the coronavirus disease 2019 (COVID-19) pandemic due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), rare cases were reported in children and adolescents of multisystem inflammatory syndrome in children (MIS-C). MIS-C is characterized by fever, systemic inflammation, and multiorgan dysfunction and usually presents late in SARS-CoV-2 infection. Since May 2020, the Centers for Disease Control and Prevention (CDC) has recorded all reported cases of COVID-19 and MIS-C in children and adolescents in the USA. In April 2021, the American College of Rheumatology (ACR) revised its clinical guidelines for diagnosing and managing hyperinflammation and MIS-C. There are several challenges ahead for preventing, diagnosing, and managing MIS-C, particularly following the rapid emergence of new strains of SARS-CoV-2. This Editorial aims to present an update on the current status of the clinical presentation, diagnosis, and management of MIS-C and includes some updates from population studies and clinical guidelines.

SUBMITTER: Parums DV 

PROVIDER: S-EPMC8176784 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

2022-11-05 | GSE217370 | GEO
2021-09-29 | PXD025462 | Pride
| S-EPMC10050384 | biostudies-literature
| S-EPMC7785920 | biostudies-literature
| S-EPMC10015103 | biostudies-literature
| S-EPMC9384566 | biostudies-literature
| S-EPMC7982656 | biostudies-literature
| S-EPMC8250955 | biostudies-literature
| S-EPMC8475320 | biostudies-literature
| S-EPMC7431129 | biostudies-literature